Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Emergencies × Levofloxacin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 3 Lymphoma, Non-Hodgkin 3 Febrile Neutropenia 3 Urinary Bladder Neoplasms 2 Sezary Syndrome 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neutropenia 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Intraocular Lymphoma 2 Infections 2 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Urinary Tract Infections 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Stem Cell Transplant Complications 1 Small Cell Lung Carcinoma 1

Interventions

Hydromorphone 2 NF protocol 1 Meropenem 1 Levofloxacin 1 Ketorolac 1 Heller Myotomy 1 Glucose 1 Fentanyl 1 Colectomy 1 Anti-Bacterial Agents 1 Amoxicillin-Potassium Clavulanate Combination 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05393505 2022-12-06

FRANCiS-NF

The University of Hong Kong

Phase 4 Unknown

Classical hematology

Emergencies, Neoplasms, Sepsis, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡